头颈部-话题@MedSci

#头颈部#

163篇内容 | 3745人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1491888, encodeId=085714918889a, content=<a href='/topic/show?id=b4f14442346' target=_blank style='color:#2F92EE;'>#头颈部#</a>, objectTitle=ESMO Open：Tomuzotuximab vs 西妥昔单抗用作复发/转移性头颈部鳞癌的一线治疗方案的疗效和安全性, objectType=article, longId=217042, objectId=d10c21e042bc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d10c21e042bc, replyNumber=0, likeNumber=67, createdTime=2021-09-15, rootId=0, userName=wshxjq, userId=0b2d8903151, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d10c21e042bc, moduleTitle=ESMO Open：Tomuzotuximab vs 西妥昔单抗用作复发/转移性头颈部鳞癌的一线治疗方案的疗效和安全性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d10c21e042bc)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1491887, encodeId=ac52149188e5a, content=<a href='/topic/show?id=b4f14442346' target=_blank style='color:#2F92EE;'>#头颈部#</a>, objectTitle=Br J Cancer：肿瘤邻近组织、血浆和唾液中相关基因突变研究揭示头颈部鳞状细胞癌复发的进化过程, objectType=article, longId=213954, objectId=133d21395428, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=133d21395428, replyNumber=0, likeNumber=69, createdTime=2021-07-10, rootId=0, userName=wshxjq, userId=0b2d8903151, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=133d21395428, moduleTitle=Br J Cancer：肿瘤邻近组织、血浆和唾液中相关基因突变研究揭示头颈部鳞状细胞癌复发的进化过程, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=133d21395428)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1491886, encodeId=aa921491886c2, content=<a href='/topic/show?id=b4f14442346' target=_blank style='color:#2F92EE;'>#头颈部#</a>, objectTitle=Cancers：放疗联合S-1治疗头颈部肿瘤的的疗效和安全性：来自Meta分析, objectType=article, longId=212730, objectId=dfbe212e30d5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=dfbe212e30d5, replyNumber=0, likeNumber=82, createdTime=2021-06-16, rootId=0, userName=wshxjq, userId=0b2d8903151, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=dfbe212e30d5, moduleTitle=Cancers：放疗联合S-1治疗头颈部肿瘤的的疗效和安全性：来自Meta分析, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=dfbe212e30d5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1491885, encodeId=95ce14918859f, content=<a href='/topic/show?id=b4f14442346' target=_blank style='color:#2F92EE;'>#头颈部#</a>, objectTitle=Lancet Oncology：Avelumab联合同步放化疗与单纯同步放化疗治疗局部晚期头颈部鳞状细胞癌：一项随机、双盲、安慰剂对照、多中心、3期试验 , objectType=article, longId=212089, objectId=fc5c2120893c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fc5c2120893c, replyNumber=0, likeNumber=65, createdTime=2021-06-01, rootId=0, userName=wshxjq, userId=0b2d8903151, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fc5c2120893c, moduleTitle=Lancet Oncology：Avelumab联合同步放化疗与单纯同步放化疗治疗局部晚期头颈部鳞状细胞癌：一项随机、双盲、安慰剂对照、多中心、3期试验 , moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fc5c2120893c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1491884, encodeId=503f149188496, content=<a href='/topic/show?id=b4f14442346' target=_blank style='color:#2F92EE;'>#头颈部#</a>, objectTitle=Oncologist：西米普利单抗+放疗+环磷酰胺+GM-CSF治疗复发/转移性头颈部鳞状细胞癌的疗效和安全性, objectType=article, longId=210895, objectId=1c9e21089525, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1c9e21089525, replyNumber=0, likeNumber=67, createdTime=2021-05-08, rootId=0, userName=wshxjq, userId=0b2d8903151, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1c9e21089525, moduleTitle=Oncologist：西米普利单抗+放疗+环磷酰胺+GM-CSF治疗复发/转移性头颈部鳞状细胞癌的疗效和安全性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1c9e21089525)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1491883, encodeId=09c614918835c, content=<a href='/topic/show?id=b4f14442346' target=_blank style='color:#2F92EE;'>#头颈部#</a>, objectTitle=Radiology：请正视头颈部MDCT的滥用！, objectType=article, longId=210805, objectId=33132108054c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=33132108054c, replyNumber=0, likeNumber=92, createdTime=2021-05-06, rootId=0, userName=wshxjq, userId=0b2d8903151, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=33132108054c, moduleTitle=Radiology：请正视头颈部MDCT的滥用！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=33132108054c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1491882, encodeId=6faf1491882b1, content=<a href='/topic/show?id=b4f14442346' target=_blank style='color:#2F92EE;'>#头颈部#</a>, objectTitle=Nat Commun：新辅助抗OX40疗法（MEDI6469）治疗头颈部鳞状细胞癌患者的临床研究, objectType=article, longId=207670, objectId=aec820e67021, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=aec820e67021, replyNumber=0, likeNumber=77, createdTime=2021-02-28, rootId=0, userName=wshxjq, userId=0b2d8903151, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=aec820e67021, moduleTitle=Nat Commun：新辅助抗OX40疗法（MEDI6469）治疗头颈部鳞状细胞癌患者的临床研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=aec820e67021)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1491881, encodeId=4d63149188133, content=<a href='/topic/show?id=b4f14442346' target=_blank style='color:#2F92EE;'>#头颈部#</a>, objectTitle=Eur Radiol:头颈部肿瘤合并少肌症如何评价？, objectType=article, longId=206190, objectId=d6a320619067, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d6a320619067, replyNumber=0, likeNumber=82, createdTime=2021-01-26, rootId=0, userName=wshxjq, userId=0b2d8903151, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d6a320619067, moduleTitle=Eur Radiol:头颈部肿瘤合并少肌症如何评价？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d6a320619067)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1491880, encodeId=7cc9149188094, content=<a href='/topic/show?id=b4f14442346' target=_blank style='color:#2F92EE;'>#头颈部#</a>, objectTitle=JCO：西妥昔单抗联合放疗治疗晚期头颈部鳞状细胞癌疗效次于顺铂, objectType=article, longId=202297, objectId=bcfe20229e68, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bcfe20229e68, replyNumber=0, likeNumber=83, createdTime=2020-10-21, rootId=0, userName=wshxjq, userId=0b2d8903151, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bcfe20229e68, moduleTitle=JCO：西妥昔单抗联合放疗治疗晚期头颈部鳞状细胞癌疗效次于顺铂, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=bcfe20229e68)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1491879, encodeId=7dfe14918e99d, content=<a href='/topic/show?id=b4f14442346' target=_blank style='color:#2F92EE;'>#头颈部#</a>, objectTitle=Clin cancer res：绿茶多酚E联合厄洛替尼可有效预防头颈部癌前病变恶变成癌, objectType=article, longId=201947, objectId=15c320194e43, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=15c320194e43, replyNumber=0, likeNumber=92, createdTime=2020-10-12, rootId=0, userName=wshxjq, userId=0b2d8903151, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=15c320194e43, moduleTitle=Clin cancer res：绿茶多酚E联合厄洛替尼可有效预防头颈部癌前病变恶变成癌, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=15c320194e43)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1491878, encodeId=e94614918e830, content=<a href='/topic/show?id=b4f14442346' target=_blank style='color:#2F92EE;'>#头颈部#</a>, objectTitle=免疫治疗头颈部鳞癌一线长生存数据公布, objectType=article, longId=201492, objectId=9afb20149296, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9afb20149296, replyNumber=0, likeNumber=57, createdTime=2020-10-03, rootId=0, userName=wshxjq, userId=0b2d8903151, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9afb20149296, moduleTitle=免疫治疗头颈部鳞癌一线长生存数据公布, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9afb20149296)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1491877, encodeId=88b014918e717, content=<a href='/topic/show?id=b4f14442346' target=_blank style='color:#2F92EE;'>#头颈部#</a>, objectTitle=Br J Cancer：Buparlisib和西妥昔单抗联合治疗改善头颈部鳞状细胞癌患者预后, objectType=article, longId=201449, objectId=7c8f201449ff, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7c8f201449ff, replyNumber=0, likeNumber=65, createdTime=2020-10-03, rootId=0, userName=wshxjq, userId=0b2d8903151, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7c8f201449ff, moduleTitle=Br J Cancer：Buparlisib和西妥昔单抗联合治疗改善头颈部鳞状细胞癌患者预后, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7c8f201449ff)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1491876, encodeId=b3dc14918e66f, content=<a href='/topic/show?id=b4f14442346' target=_blank style='color:#2F92EE;'>#头颈部#</a>, objectTitle=Nat Commun：VAV2促进皮肤和头颈部鳞状细胞癌的再生性增殖, objectType=article, longId=201185, objectId=f7e020118541, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f7e020118541, replyNumber=0, likeNumber=87, createdTime=2020-09-26, rootId=0, userName=wshxjq, userId=0b2d8903151, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f7e020118541, moduleTitle=Nat Commun：VAV2促进皮肤和头颈部鳞状细胞癌的再生性增殖, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f7e020118541)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1491875, encodeId=731614918e516, content=<a href='/topic/show?id=b4f14442346' target=_blank style='color:#2F92EE;'>#头颈部#</a>, objectTitle=Br J Cancer：尼妥珠单抗联合顺铂放疗改善高HIF1α表达的局部晚期头颈部鳞癌患者的预后, objectType=article, longId=201080, objectId=d88e20108084, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d88e20108084, replyNumber=0, likeNumber=83, createdTime=2020-09-24, rootId=0, userName=wshxjq, userId=0b2d8903151, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d88e20108084, moduleTitle=Br J Cancer：尼妥珠单抗联合顺铂放疗改善高HIF1α表达的局部晚期头颈部鳞癌患者的预后, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d88e20108084)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1491874, encodeId=8c1714918e4a0, content=<a href='/topic/show?id=b4f14442346' target=_blank style='color:#2F92EE;'>#头颈部#</a>, objectTitle=HNCDB——强大的头颈部肿瘤数据库平台, objectType=article, longId=199532, objectId=3b0619953204, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3b0619953204, replyNumber=0, likeNumber=102, createdTime=2020-08-17, rootId=0, userName=wshxjq, userId=0b2d8903151, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3b0619953204, moduleTitle=HNCDB——强大的头颈部肿瘤数据库平台, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3b0619953204)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1491873, encodeId=953814918e3e9, content=<a href='/topic/show?id=b4f14442346' target=_blank style='color:#2F92EE;'>#头颈部#</a>, objectTitle=Lancet oncol：Debio 1143治疗局部晚期头颈部鳞状细胞癌, objectType=article, longId=198710, objectId=a8d7198e10e3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a8d7198e10e3, replyNumber=0, likeNumber=40, createdTime=2020-08-06, rootId=0, userName=wshxjq, userId=0b2d8903151, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a8d7198e10e3, moduleTitle=Lancet oncol：Debio 1143治疗局部晚期头颈部鳞状细胞癌, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a8d7198e10e3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1491872, encodeId=78fc14918e2a6, content=<a href='/topic/show?id=b4f14442346' target=_blank style='color:#2F92EE;'>#头颈部#</a>, objectTitle=Cancer：二甲双胍联合顺铂和放疗治疗局部晚期头颈部鳞状细胞癌的效果, objectType=article, longId=198497, objectId=df1419849e05, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=df1419849e05, replyNumber=0, likeNumber=67, createdTime=2020-08-02, rootId=0, userName=wshxjq, userId=0b2d8903151, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=df1419849e05, moduleTitle=Cancer：二甲双胍联合顺铂和放疗治疗局部晚期头颈部鳞状细胞癌的效果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=df1419849e05)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1491871, encodeId=5d2b14918e11b, content=<a href='/topic/show?id=b4f14442346' target=_blank style='color:#2F92EE;'>#头颈部#</a>, objectTitle=头颈部肿瘤放疗前景展望, objectType=article, longId=198271, objectId=6bf91982e1b2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6bf91982e1b2, replyNumber=0, likeNumber=81, createdTime=2020-07-30, rootId=0, userName=wshxjq, userId=0b2d8903151, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6bf91982e1b2, moduleTitle=头颈部肿瘤放疗前景展望, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6bf91982e1b2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1491870, encodeId=a91714918e02d, content=<a href='/topic/show?id=b4f14442346' target=_blank style='color:#2F92EE;'>#头颈部#</a>, objectTitle=围绕四大基本问题构建，原发灶不明的头颈部鳞癌指南的诊断及治疗原则解读, objectType=article, longId=198222, objectId=6802198222f9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6802198222f9, replyNumber=0, likeNumber=60, createdTime=2020-07-30, rootId=0, userName=wshxjq, userId=0b2d8903151, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6802198222f9, moduleTitle=围绕四大基本问题构建，原发灶不明的头颈部鳞癌指南的诊断及治疗原则解读, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6802198222f9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1491869, encodeId=8e391491869e5, content=<a href='/topic/show?id=b4f14442346' target=_blank style='color:#2F92EE;'>#头颈部#</a>, objectTitle=Support Care Cancer：多模态运动改善接受化疗的头颈部癌症患者的运动反应和身体成分, objectType=article, longId=196281, objectId=6daa196281cd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6daa196281cd, replyNumber=0, likeNumber=74, createdTime=2020-06-24, rootId=0, userName=wshxjq, userId=0b2d8903151, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6daa196281cd, moduleTitle=Support Care Cancer：多模态运动改善接受化疗的头颈部癌症患者的运动反应和身体成分, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6daa196281cd)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

头颈部

2020-05-29

wshxjq (审核中...)

前往app查看评论内容

#头颈部#

ESMO Open：Tomuzotuximab vs 西妥昔单抗用作复发/转移性头颈部鳞癌的一线治疗方案的疗效和安全性

2021-09-15

wshxjq (审核中...)

前往app查看评论内容

#头颈部#

Br J Cancer：肿瘤邻近组织、血浆和唾液中相关基因突变研究揭示头颈部鳞状细胞癌复发的进化过程

2021-07-10

wshxjq (审核中...)

前往app查看评论内容

#头颈部#

Cancers：放疗联合S-1治疗头颈部肿瘤的的疗效和安全性：来自Meta分析

2021-06-16

wshxjq (审核中...)

前往app查看评论内容

#头颈部#

Lancet Oncology：Avelumab联合同步放化疗与单纯同步放化疗治疗局部晚期头颈部鳞状细胞癌：一项随机、双盲、安慰剂对照、多中心、3期试验

2021-06-01

wshxjq (审核中...)

前往app查看评论内容

#头颈部#

Oncologist：西米普利单抗+放疗+环磷酰胺+GM-CSF治疗复发/转移性头颈部鳞状细胞癌的疗效和安全性

2021-05-08

wshxjq (审核中...)

前往app查看评论内容

#头颈部#

Radiology：请正视头颈部MDCT的滥用！

2021-05-06

wshxjq (审核中...)

前往app查看评论内容

#头颈部#

Nat Commun：新辅助抗OX40疗法（MEDI6469）治疗头颈部鳞状细胞癌患者的临床研究

2021-02-28

wshxjq (审核中...)

前往app查看评论内容

#头颈部#

Eur Radiol:头颈部肿瘤合并少肌症如何评价？

2021-01-26

wshxjq (审核中...)

前往app查看评论内容

#头颈部#

JCO：西妥昔单抗联合放疗治疗晚期头颈部鳞状细胞癌疗效次于顺铂

2020-10-21

wshxjq (审核中...)

前往app查看评论内容

#头颈部#

Clin cancer res：绿茶多酚E联合厄洛替尼可有效预防头颈部癌前病变恶变成癌

2020-10-12

wshxjq (审核中...)

前往app查看评论内容

#头颈部#

免疫治疗头颈部鳞癌一线长生存数据公布

2020-10-03

wshxjq (审核中...)

前往app查看评论内容

#头颈部#

Br J Cancer：Buparlisib和西妥昔单抗联合治疗改善头颈部鳞状细胞癌患者预后

2020-10-03

wshxjq (审核中...)

前往app查看评论内容

#头颈部#

Nat Commun：VAV2促进皮肤和头颈部鳞状细胞癌的再生性增殖

2020-09-26

wshxjq (审核中...)

前往app查看评论内容

#头颈部#

Br J Cancer：尼妥珠单抗联合顺铂放疗改善高HIF1α表达的局部晚期头颈部鳞癌患者的预后

2020-09-24

wshxjq (审核中...)

前往app查看评论内容

#头颈部#

HNCDB——强大的头颈部肿瘤数据库平台

2020-08-17

wshxjq (审核中...)

前往app查看评论内容

#头颈部#

Lancet oncol：Debio 1143治疗局部晚期头颈部鳞状细胞癌

2020-08-06

wshxjq (审核中...)

前往app查看评论内容

#头颈部#

Cancer：二甲双胍联合顺铂和放疗治疗局部晚期头颈部鳞状细胞癌的效果

2020-08-02

wshxjq (审核中...)

前往app查看评论内容

#头颈部#

头颈部肿瘤放疗前景展望

2020-07-30

wshxjq (审核中...)

前往app查看评论内容

#头颈部#

围绕四大基本问题构建，原发灶不明的头颈部鳞癌指南的诊断及治疗原则解读

2020-07-30

wshxjq (审核中...)

前往app查看评论内容

#头颈部#

Support Care Cancer：多模态运动改善接受化疗的头颈部癌症患者的运动反应和身体成分

2020-06-24

科室
- - 订阅+
  - 更多科室
工具
服务